Link: http://parkinsonsfocustoday.blogspot.com/2010/05/how-much-antifreeze-does-parkinsons.html

SINEMET CR
CARBIDOPA-LEVODOPA

100 TABLETS
Only $ 170.84
Buy Now

The news for US Parkinson's Disease patients waiting for an early FDA clearance of the Neurpro patch formulation is not good. On April 23, 2010 UCB announced the receipt of the FDA response letter. The FDA informed UCB Pharma that it will have to resolve all crystallization issues with the Neupro® patch. Apparently the policy is zero tolerance despite the fact that the patch was returned to the European market about 10 months ago.

The good news for PD patients around the world with the exception of the USA are the results of the RECOVER study were presented in at the American Academy of Neurology annual meeting in Toronto, Canada in April, 2010. The data demonstrated the rotigotine improved both early morning motor function and improved non-motor symptoms in Parkinson's patients. Symptoms such as sleep, mood, cognition and pain were measured and found to be improved. Nocturia, night time excessive urination remained unchanged and there were some adverse events such as site reactions, nausea and dizziness in both the rotigotine group and the placebo group. Rotigotine was shown to be effective up to 6 years and provided improvement in movement symptoms for up to 6 years.

But as always, US Customers are not out of luck! If you require Neupro, you can still order it from ibenefitRx. We ship right to your door, delivery 100% Guaranteed!